Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon
- PMID: 22144441
- PMCID: PMC3225149
- DOI: 10.4269/ajtmh.2011.11-0333
Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon
Abstract
We studied onchocerciasis transmission and impact on ocular morbidity in three health districts in North Region, Cameroon, where annual mass ivermectin treatment has been provided for 12-17 years. The studies, which took place from 2008 to 2010, consisted of skin snips for microfilariae (mf), palpation examinations for nodules, slit lamp examinations for mf in the eye, and Simulium vector dissections for larval infection rates. Adults had mf and nodule rates of 4.8% and 13.5%, respectively, and 5.5% had mf in the anterior chamber of the eye. Strong evidence of ongoing transmission was found in one health district, where despite 17 years of annual treatments, the annual transmission potential was 543 L3/person per year; additionally, children under 10 years of age had a 2.6% mf prevalence. Halting ivermectin treatments in North Cameroon now might risk recrudescence of transmission and ocular disease.
Figures
References
-
- Bottomley C, Isham V, Collins RC, Basáñez MG. Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology. 2008;135:1571–1581. - PubMed
-
- Cupp EW, Cupp MS. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg. 2005;73:159–161. - PubMed
-
- Report WHO. African Programme for Onchocerciasis Control—report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec. 2010;4:23–28. - PubMed
-
- Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M, Ntep M, Richards FO. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop Med Int Health. 2008;13:1196–1203. - PubMed
-
- Boatin BA, Hougard JM, Alley ES, Akpoboua LK, Yaméogo L, Dembélé N, Sékétéli A, Dadzie KY. The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol. 1998;92:S46–S60. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
